- Home
- OZ vs DCTH Comparison
OZ vs DCTH Comparison
Compare OZ & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OZ
- DCTH
- Stock Information
- Founded
- OZ 2020
- DCTH 1988
- Country
- OZ United States
- DCTH United States
- Employees
- OZ N/A
- DCTH N/A
- Industry
- OZ
- DCTH Medical/Dental Instruments
- Sector
- OZ
- DCTH Health Care
- Exchange
- OZ Nasdaq
- DCTH Nasdaq
- Market Cap
- OZ 237.4M
- DCTH 207.5M
- IPO Year
- OZ N/A
- DCTH N/A
- Fundamental
- Price
- OZ $66.01
- DCTH $9.67
- Analyst Decision
- OZ
- DCTH Strong Buy
- Analyst Count
- OZ 0
- DCTH 4
- Target Price
- OZ N/A
- DCTH $21.50
- AVG Volume (30 Days)
- OZ 9.0K
- DCTH 321.0K
- Earning Date
- OZ 01-01-0001
- DCTH 08-05-2024
- Dividend Yield
- OZ N/A
- DCTH N/A
- EPS Growth
- OZ N/A
- DCTH N/A
- EPS
- OZ N/A
- DCTH N/A
- Revenue
- OZ $1,700,000.00
- DCTH $11,878,000.00
- Revenue This Year
- OZ N/A
- DCTH $1,519.13
- Revenue Next Year
- OZ N/A
- DCTH $123.51
- P/E Ratio
- OZ N/A
- DCTH N/A
- Revenue Growth
- OZ N/A
- DCTH 350.44
- 52 Week Low
- OZ $42.75
- DCTH $2.25
- 52 Week High
- OZ $90.50
- DCTH $11.75
- Technical
- Relative Strength Index (RSI)
- OZ 55.84
- DCTH 56.02
- Support Level
- OZ $64.31
- DCTH $10.35
- Resistance Level
- OZ $65.50
- DCTH $11.04
- Average True Range (ATR)
- OZ 1.32
- DCTH 0.72
- MACD
- OZ 0.32
- DCTH 0.14
- Stochastic Oscillator
- OZ 100.00
- DCTH 50.65
About OZ Belpointe PREP LLC Units
Belpointe PREP LLC is a qualified opportunity fund. The company's investments consist of properties located in qualified opportunity zones for the development or redevelopment of multifamily, student housing, senior living, healthcare, industrial, self-storage, hospitality, office, mixed-use, data centers, and solar projects located throughout the United States and its territories.
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.